Board approves promoter investment via convertible warrants in subsidiary

Fund Raising View source PDF Explain this filing

VIRINCHI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹20.13

prior close

₹19.35

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%+1.7% vs market

Software Products peers, median of 36sector-0.3%+1.2% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.2 pts more than its Software Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

+0.4

15m

+1.8

30m

+1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9-0.8+1.7-0.3+1.2

Next day

+2.0+0.7+1.3+0.3+1.8

-3.9-1.4-2.4-0.6-3.2

-2.1-1.3-0.8-1.5-0.5

+2.3+0.7+1.6-0.5+2.9

+3.8+0.3+3.5-0.8+4.6

+0.1+0.9-0.8+0.3-0.2

15d

+2.3+6.8-4.4+2.9-0.6

-0.9+4.3-5.2+4.4-5.3

-20.7-8.7-12.0-10.9-9.8

-10.1+8.6-18.7-2.2-7.9

UpDownMarket · Nifty Microcap 250Sector · Software Products peers, median of 36Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved seeking shareholder approval via postal ballot for promoter Mr. Viswanath Kompella to invest in material subsidiary Virinchi Health Care via 52.22 lakh convertible equity warrants at Rs. 15 each (Face Value Rs. 10 plus Premium Rs. 5). Post-issue, promoter stake in subsidiary will not exceed 49 percent. Subsidiary valued at Rs. 312.08 crore. Warrants convertible within 36 months. Investment aims to improve subsidiary balance sheet and liquidity.

Likely market impact

Promoter commitment signals confidence in subsidiary growth. May improve subsidiary liquidity and balance sheet, subject to shareholder approval via postal ballot.